Token classification is one of the highest-stakes legal questions in digital-asset practice. A misstep — classifying a security token as a utility token, or issuing a whitepaper that fails the applicable disclosure test — can convert a product launch into an unregistered securities offering, triggering enforcement, rescission claims, and cross-border liability across every jurisdiction where purchasers reside. The token sale agreement is the document that defines those stakes in writing: it allocates risk, establishes the nature of the instrument, and either insulates the issuer from regulatory liability or amplifies it. This analysis maps the legal lines that agreement drafters must draw, the contrasting positions regulators take across key hubs, and the structural choices that determine whether a token offering survives scrutiny.
What a Token Sale Agreement Must Accomplish Before Anything Else
A well-drafted token sale agreement does more than record a transaction: it operationalizes the issuer's classification position, incorporates the applicable regulatory framework, and allocates the legal consequences of mis-classification between issuer and purchaser. The document is simultaneously a commercial contract, a compliance record, and, in contested proceedings, the primary exhibit regulators and courts examine first. Its core function is to characterize the token — precisely, consistently with the whitepaper, and in terms that hold up against the substance-over-label test applied by regulators from the SEC and CFTC in the United States to ESMA and national competent authorities under MiCA. Any gap between what the agreement says and what the token actually does is a gap that enforcement can exploit.
Operators we advise regularly underestimate the contractual dimension of classification. They focus on the whitepaper — the public-facing document — while the purchase agreement remains a secondary drafting exercise. That inversion is a structural mistake. Regulators and claimants read both documents together. Where they conflict, the agreement typically governs as between the parties; where both conflict with on-chain mechanics, the on-chain mechanics govern as between the token and the world. Drafting must account for all three layers simultaneously.
The cross-border reality compounds this. A token issuer domiciled in one jurisdiction, with purchasers in a dozen others and exchange listings in three more, is not operating under a single legal regime. The agreement must address the issuer's primary jurisdiction, the purchaser's residence as a choice-of-law and jurisdiction variable, and the regulatory status of the token in each market where it will trade. These are not identical questions, and a single governing-law clause does not resolve all of them.
Token Classification: The Threshold Question That Governs Everything Else
Token classification determines the entire regulatory architecture of an offering — and it is assessed against the substance of rights the token confers, never against the label the issuer applies. This principle is not new, but it is routinely misapplied. A whitepaper that describes a token as a "utility token" grants the issuer no protection if the token confers profit expectations derived from the issuer's managerial efforts. The rights analysis is the analysis.
The dominant test in the US market is the Howey framework — whether the instrument involves an investment of money in a common enterprise with an expectation of profits from the efforts of others. The SEC has applied this test consistently to token offerings. In practice, the test turns on fact-intensive questions: does the token appreciate in value because of the issuer's development efforts? Do purchasers acquire the token primarily to use it or primarily to profit from it? Is the "utility" functional at the point of sale, or is it promised functionality contingent on future development?
Under MiCA, the classification axis is different but comparably rigorous. MiCA distinguishes between asset-referenced tokens (ARTs, referencing a basket of assets or currencies), e-money tokens (EMTs, referencing a single fiat currency), and other crypto-assets, including tokens that may qualify as financial instruments under MiFID II. The MiCA whitepaper obligation, and the authorization track, depends on which category applies. Tokens classified as MiFID II financial instruments fall outside MiCA entirely and into the existing securities regime — a consequence that transforms the offering from a whitepaper-registration exercise into a full prospectus and authorization requirement.
The practical tension in agreement drafting: the issuer wants language that supports a utility or other-crypto-asset classification; the purchaser's counsel (where engaged) wants representations that the token is not a security; and regulators in multiple jurisdictions are examining the same instrument against their own tests. The agreement cannot resolve conflicting regulatory positions, but it can — and must — document the issuer's classification reasoning, state the jurisdictions in which no offer was made, and include representations and warranties that are accurate under the law of the governing jurisdiction.
A common assumption is that a utility label on a whitepaper settles the legal classification. It does not, in any jurisdiction. The label is a starting point for analysis, not a conclusion. We assess classification against the substance of rights the token confers — the actual economic exposure, governance rights, and profit linkage — before advising on document structure.
How Securities Law Fractures Across Key Jurisdictions
The absence of a global token classification standard means that a single offering can be a utility instrument in one jurisdiction, a financial instrument requiring prospectus disclosure in a second, and a payment instrument subject to e-money rules in a third — simultaneously. Managing this multiplicity is the core cross-border drafting challenge.
In the United States, the SEC's position has been consistently expansive: most tokens issued in connection with a fundraise — where purchasers expect appreciation based on issuer effort — are treated as securities. The agreement must include robust investor-qualification provisions (accredited investor verification under Regulation D, or equivalent), jurisdiction-specific exclusion language, and representations designed to support the exemption relied upon. CFTC jurisdiction attaches separately if the token is classified as a commodity derivative or if leveraged trading is involved.
In the EU, MiCA creates a more structured classification pathway, but it does not eliminate complexity. Issuers and their counsel must assess whether the token fits the ART, EMT, or other-crypto-asset category; prepare the applicable whitepaper; and notify or seek authorization from the relevant national competent authority. ESMA has published guidance on the boundary between MiCA instruments and MiFID II financial instruments, but the line remains fact-specific. A token that gives holders governance rights over a protocol generating fee revenue may cross into financial-instrument territory regardless of how it is labeled.
In Singapore, MAS under the Payment Services Act distinguishes between digital payment tokens (DPTs) and capital markets products. Tokens that fall within the definition of a capital markets product are subject to the Securities and Futures Act and its prospectus regime; tokens outside that definition may be issued with fewer formal restrictions but remain subject to AML/CFT requirements. The MAS takes a substance-over-form approach aligned with the international consensus.
In the UAE, VARA in Dubai operates an activity-based licensing regime that governs the issuance and sale of virtual assets. Issuers and intermediaries engaged in the Dubai market require the applicable VARA authorization before commencing an offering. ADGM's FSRA regime in Abu Dhabi applies a separate recognized-virtual-asset framework. An issuer with UAE purchasers must assess both regimes, because the geographic scope of VARA and ADGM are distinct.
In our cross-border practice, the most common error is not getting one jurisdiction wrong — it is failing to map all the jurisdictions that are actually engaged. A purchaser base spread across the EU, the US, and the Gulf creates three separate regulatory exposures, each with different agreement requirements and different consequences for non-compliance. The agreement's jurisdiction-exclusion provisions are only as effective as the KYC and geo-blocking mechanics that enforce them.
To map your offering's multi-jurisdictional exposure before the agreement is finalized, contact OBOLUS at our contact page. The analysis above describes the standard cross-border positions. The specific risk profile — entity location, purchaser base, token mechanics, exchange strategy — determines which frameworks apply and in what order.
Key Clauses That Draw the Legal Lines
The legal lines in a token sale agreement are drawn clause by clause, and each clause either supports or undermines the issuer's classification position, liability exposure, and enforcement risk. Several clauses carry disproportionate weight.
The nature-of-the-token clause defines what the token is and what rights it confers. This clause must be accurate, consistent with the whitepaper, and drafted in terms that track the applicable classification test. An issuer relying on a utility classification should document the specific, existing utility the token provides at the point of sale — not utility to be developed post-funding. Vague descriptions of "access rights" or "future ecosystem participation" invite reclassification.
The no-expectation-of-profit clause addresses the investment-return dimension of the Howey test and its analogues in other jurisdictions. Purchasers represent that they are not acquiring the token primarily as an investment. This clause has limited standalone force — a purchaser who actually bought for profit cannot be contractually prevented from arguing that fact — but it contributes to the pattern of documentation regulators review when assessing the overall offering.
The purchaser-qualification clause identifies the applicable exemption (accredited investor, sophisticated investor, institutional purchaser) and requires the purchaser to represent their status. For US-facing offerings, this clause must be operationalized through verified KYC — a representation without verification is not a safe harbor.
The jurisdiction-exclusion clause lists the territories in which no offer is made and prohibits persons in those territories from participating. Its effectiveness depends entirely on the geo-blocking, IP restrictions, and KYC processes that enforce it. A jurisdiction-exclusion clause in the agreement that is contradicted by open access to the sale portal is worse than no clause at all — it demonstrates awareness of the issue without implementing a solution.
The risk factors section should document the specific regulatory uncertainty the token faces — classification risk, the possibility of future regulatory reclassification, secondary-market restrictions, and smart-contract risk. Risk factors serve a dual purpose: they are disclosure obligations in many jurisdictions, and they are defenses in rescission and misrepresentation claims.
The governing law and jurisdiction clause is frequently under-engineered. For a multi-jurisdictional offering, the choice of a single governing law does not resolve conflicts of mandatory law in the purchaser's jurisdiction. Some legal systems treat investor-protection rules as mandatory regardless of choice-of-law agreements. Drafters must assess whether the chosen law's investor-protection minimum is sufficient to displace competing mandatory rules, or whether a multi-tier dispute resolution structure — arbitration for commercial claims, recognition of local court jurisdiction for regulatory enforcement — better reflects the actual exposure.
Whitepaper and Agreement Alignment: Where Conflicts Become Claims
Divergence between the whitepaper and the sale agreement is one of the most common and consequential drafting failures we see in token offerings. The whitepaper is typically drafted first, by a marketing-oriented team, and describes the token's vision, mechanics, and use case in terms designed to attract interest. The agreement is drafted later, often under time pressure, and is sometimes treated as a standard-form document to be adapted from a previous offering. When the two documents describe the token differently — different rights, different timelines, different regulatory characterizations — the divergence creates the factual predicate for misrepresentation and breach-of-contract claims.
Under MiCA, the whitepaper is a formal disclosure document with specific mandatory content requirements. Issuers are responsible for the accuracy of the whitepaper and must update it when material changes occur. A whitepaper that makes forward-looking statements about token utility that are not reflected in the agreement's risk factors, or that describes a governance structure the agreement does not implement, creates both a regulatory exposure (incomplete or misleading disclosure) and a private-law exposure (contractual misrepresentation).
In our practice, we review the whitepaper and the purchase agreement in parallel, specifically to identify and resolve divergences before the offering opens. The most common divergence involves timeline representations: the whitepaper describes a product development roadmap; the agreement disclaims any commitment to that roadmap. The disclaimer is necessary — but it must be drafted to preserve the roadmap as aspirational without creating a representation that the issuer has no development obligations at all. The latter formulation can be used to support claims that the token was never intended to provide genuine utility.
A micro-matter illustrates the point. Earlier this year, a token issuer approached us after receiving a purchaser claim alleging that the token's whitepaper described staking functionality that the sale agreement's technology-disclaimer clause appeared to exclude. The claimant argued that the agreement, read against the whitepaper, demonstrated that the issuer knew staking functionality would not be delivered and had omitted a material risk factor. We reviewed the documents together, identified the specific textual divergence, and advised on the contractual defense and the additional disclosure that would need to accompany any secondary-market activity. The matter was resolved through structured documentation before proceedings commenced.
If a purchaser dispute has already surfaced — or if a whitepaper and agreement drafted separately need a cross-document review — write to OBOLUS at our contact page. A second read can surface the structural divergence and the route forward.
How Should an Airdrop or Community Distribution Be Structured Legally?
An airdrop — a distribution of tokens to wallet addresses, typically without direct payment — is not automatically exempt from securities law or other regulatory requirements. The classification question applies equally to airdropped tokens; the absence of a sale price does not remove the expectation-of-profit analysis or the regulatory perimeter. Structuring an airdrop requires the same classification discipline as a paid offering, with additional considerations specific to the distribution mechanism.
The first question is whether the recipients are identifiable and subject to KYC obligations. Under FATF's Recommendation 15 and the Travel Rule (the obligation to pass originator and beneficiary data with a virtual-asset transfer), jurisdictions that have implemented the Travel Rule at or above the applicable de-minimis threshold may require VASPs involved in the distribution to collect and transmit recipient information. The threshold and obligation scope vary by jurisdiction and must be assessed against current local implementation.
The second question is whether the distribution is truly gratuitous or whether it constitutes consideration for a prior or future obligation. Retroactive airdrops — tokens distributed to users who previously interacted with a protocol — may constitute deferred compensation for those prior interactions. If those prior interactions involved an expectation of reward, the airdrop may be closer in substance to a deferred-payment sale than a gift. The agreement structure — if any agreement is used — should document the basis of the distribution and the absence of a prior commercial commitment.
The third question is the issuer's relationship to the recipients' subsequent on-exchange trading. If the issuer controls a significant proportion of the supply post-airdrop and participates in secondary-market trading, the combination of distribution and market activity may bring the issuer within the definition of a market manipulator or unregistered dealer under applicable securities law. The agreement structure should address lockup periods, sales restrictions, and the issuer's trading policy.
Community-distribution programs that combine an airdrop with a task-completion requirement — follow this account, join this Discord, share this post — are treated as promotional distributions in most jurisdictions. Where the task involves a financial consideration (referring a paying purchaser, contributing liquidity), the promotional distribution may cross into the definition of a financial promotion or an unlicensed dealing activity. Under the FCA's financial-promotion rules in the UK, such campaigns must be approved by an authorized person or fall within a specific exemption.
Decision Matrix: Which Structure Fits Which Issuer Profile?
Issuers approach token offerings from different structural positions, and the appropriate agreement architecture differs accordingly. The following profiles cover the principal configurations we see in practice.
Profile A — Early-stage protocol issuer, no functional product at launch. The token sale precedes product launch; the primary offering rationale is funding development. This profile carries the highest classification risk under the Howey analysis and its analogues: purchasers are acquiring a token whose value is contingent on the issuer's development efforts. The agreement should: document existing utility (if any), include the most robust no-expectation-of-profit representations, restrict sale to accredited or institutional purchasers in applicable jurisdictions, implement tight jurisdiction exclusions for high-scrutiny markets, and include a staged-delivery mechanic (SAFT or equivalent) where the token is delivered only upon a defined protocol milestone. Timeline from agreement drafting to closing typically spans several weeks to a few months depending on KYC volume and milestone definition.
Profile B — Established protocol, functional product, secondary offering. The token has already been in circulation; the issuer is conducting a secondary sale, possibly to fund ecosystem development. Classification risk is lower if the product is genuinely functional and independent of issuer effort — but the secondary-offering mechanics introduce additional regulatory questions, particularly in EU markets under MiCA (where a new whitepaper obligation may be triggered) and in US markets (where the Howey analysis applies to each new offering independently). The agreement should address the existing-utility case clearly, incorporate a whitepaper update process, and document the secondary-market disclosure obligations.
Profile C — Stablecoin issuer, EU or UK market. Under MiCA, an ART or EMT issuer is subject to authorization requirements, reserve rules, and whitepaper obligations specific to the stablecoin category. The token sale agreement for an EMT issuer functions as a hybrid between a purchase contract and a payment service agreement: it incorporates the issuer's redemption obligations, the reserve-backing assurance, and the regulatory authorization status. Agreement drafting requires coordination with the authorization application and must be consistent with the whitepaper filed with the national competent authority.
Profile D — Institutional private placement, sophisticated purchasers only. This profile minimizes public-offering exposure by limiting distribution to a defined class of institutional or sophisticated purchasers under the applicable exemption. The agreement can include stronger commercial terms — milestone-linked pricing, lockup schedules, governance rights — without the same concern about retail-investor protection rules. The key drafting priority is accurate purchaser qualification and a waterproof jurisdiction-exclusion mechanism. Timeline to close is typically shorter than a public offering; the main variable is purchaser due diligence on the issuer side.
Regulatory Enforcement and the Post-Issuance Risk Window
Token issuers frequently treat regulatory risk as a pre-launch concern. In practice, the risk window does not close at the end of the sale period. Post-issuance, the token enters secondary markets, attracts a broader holder base, and may be listed on regulated exchanges that apply their own classification analysis. Each of these events can revive regulatory exposure for an issuer that believed the offering was completed.
In the United States, enforcement actions against token issuers have followed secondary-market listings by months or years after the original sale. The SEC's analysis in these cases focused on the post-listing conduct of the issuer — continued development effort, marketing of appreciation potential, and promotional activity — as evidence that the token continued to meet the Howey test after it began trading. The sale agreement's language about the issuer's post-sale obligations matters in this analysis: broad post-sale development commitments can reinforce the argument that the token's value remains linked to issuer effort.
Under MiCA, issuers of significant ARTs and EMTs face ongoing supervisory engagement with ESMA and national competent authorities after authorization. The whitepaper must be updated on material changes; the agreement should incorporate a mechanism for notifying purchasers of material whitepaper updates where the updated terms affect their rights. This is a live drafting obligation, not a one-time disclosure event.
Exchange listing due diligence is itself a regulatory risk vector. Regulated exchanges in Singapore (under MAS), Hong Kong (under the SFC VATP regime), and the EU (under MiCA) conduct their own classification analysis of tokens they list. An exchange that reaches a different classification conclusion than the issuer may delist the token or require additional disclosure. The agreement cannot compel an exchange to reach any particular conclusion, but it can provide the documentation — classification memorandum, whitepaper, legal opinion — that supports the issuer's position in listing due diligence.
In our cross-border practice, we advise issuers to treat the agreement and supporting documentation not as a closing deliverable but as a living compliance record. Post-issuance, the record should be updated to reflect regulatory developments, secondary-market activity, and any material changes to the token's rights or mechanics. An issuer that can demonstrate a consistent, documented classification position — maintained from pre-launch through secondary trading — is in a materially stronger position in any enforcement or litigation context.
Related Practices at OBOLUS
Related at OBOLUS
- Token Offerings & Securities for Digital-Asset Businesses – end-to-end legal support for token issuance, classification, and regulatory filings
- Stablecoin Issuance Authorization in the United Kingdom – FCA authorization pathway and agreement requirements for UK stablecoin issuers
- PSP and Acquiring Agreement in Brazil – payment-service and acquiring agreement structuring for digital-asset businesses operating in Brazil
FAQ
Is my token a security?
The answer depends on the rights the token confers, not the label applied to it. In the US, the Howey analysis asks whether the instrument involves an investment of money in a common enterprise with an expectation of profits from the efforts of others. In EU markets under MiCA, the classification axis turns on whether the token is an ART, EMT, or financial instrument under MiFID II. In Singapore under the Payment Services Act, the question is whether the token is a capital markets product. Each jurisdiction applies a substance-over-form test. A legal classification review against the token's actual mechanics, rights, and target markets is the only reliable path to an answer.
Do I need a MiCA whitepaper?
If you are issuing crypto-assets in the EU — or marketing them to EU purchasers — and those assets are not financial instruments under MiFID II, a MiCA whitepaper obligation likely applies. The specific track (ART, EMT, or other-crypto-asset) determines the content requirements and whether authorization from a national competent authority is required before publication. Exempt categories exist for tokens issued in small volumes, to a limited number of purchasers, or for free. Whether your offering falls within an exemption requires a fact-specific assessment against the applicable MiCA provisions and ESMA guidance.
How should an airdrop be structured legally?
An airdrop is not automatically exempt from securities law, AML obligations, or financial-promotion rules. The structuring analysis covers: whether recipients require KYC under Travel Rule obligations in the relevant jurisdictions; whether the distribution constitutes deferred consideration for prior interactions; whether the issuer's subsequent market activity creates dealing or manipulation exposure; and whether a task-completion requirement converts the airdrop into a regulated financial promotion. The agreement or distribution terms should document the basis of the distribution, applicable lockup or resale restrictions, and the jurisdictions where no distribution is made.
About OBOLUS. OBOLUS is an independent digital-asset law boutique acting only for businesses. We advise exchanges, custodians, token issuers and funds on licensing across 70+ jurisdictions, on disputes and on-chain asset recovery across 25+ forums, and on the tax, banking and compliance that sit around them. Digital assets are the whole of our practice. We assess token classification against the substance of rights, not the marketing label — and our disputes team coordinates freezing relief and on-chain tracing across leading common-law forums where a misclassified or fraudulent offering has resulted in loss. To discuss your situation, contact info@oboluslaw.com.
By Glen Sorensen, Disputes & Recovery Analyst — specializes in cross-border token dispute strategy, sale agreement risk analysis, and on-chain asset recovery across common-law and civil-law forums.
This publication is general information about the law and does not constitute legal advice. It is not a substitute for advice tailored to your circumstances. OBOLUS accepts no liability for action taken or not taken on the basis of this material. For advice on your situation, contact info@oboluslaw.com.